Equities

Techno Medica Co Ltd

6678:TYO

Techno Medica Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,785.00
  • Today's Change21.00 / 1.19%
  • Shares traded7.60k
  • 1 Year change-0.06%
  • Beta0.2144
Data delayed at least 20 minutes, as of May 21 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Techno Medica Co., Ltd. is a Japan-based company mainly engaged in development, manufacture, sale and export of analysis device for clinical examination equipment and other medical equipment, as well as devices repair services. The blood collection tube preparation apparatus business provides blood collection peripheral equipment, such as blood and urine collection automation reception equipment, among others, as well as blood tube preparation systems. The laboratory test apparatus business provides blood gas analysis apparatus, electrolyte analyzers, erythrocyte sedimetation rate measuring machines, among others. The consumable goods business provides blood collecting tubes, labels, sensor cards, calibration packs, among others, as well as maintenance services.

  • Revenue in JPY (TTM)10.28bn
  • Net income in JPY1.35bn
  • Incorporated1987
  • Employees225.00
  • Location
    Techno Medica Co Ltd5-5-1, Nakamachidai, Tsuzuki-kuYOKOHAMA-SHI 224-0041JapanJPN
  • Phone+81 459481961
  • Fax+81 459481962
  • Websitehttps://www.technomedica.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Koken Ltd10.04bn538.47m8.26bn287.0014.860.64668.190.8232108.96108.962,031.292,503.850.47272.222.6434,975,880.002.543.703.174.7545.5046.695.367.191.8819.130.33325.88-0.16054.92-15.8414.33-39.876.96
Create Medic Co Ltd12.69bn83.34m9.29bn962.00104.670.572413.450.73189.189.181,395.571,678.910.66781.734.3913,193,190.000.43853.000.51453.5343.6845.360.65674.602.98--0.050363.222.103.11-68.06-25.530.66271.12
DVx Inc45.85bn172.91m10.82bn319.0060.461.1417.890.23616.6116.614,394.81880.721.9826.604.02--0.74743.111.777.5710.3911.600.37711.491.51--0.001447.57-3.442.57-81.53-29.2311.2315.81
JMS Co Ltd65.29bn-36.00m13.33bn5.65k--0.32524.740.2042-1.49-1.492,668.181,657.260.82072.784.07---0.05781.33-0.08651.9721.5924.29-0.07051.570.987--0.397943.412.432.38-112.81---2.421.22
OLBA Healthcare Holdings Inc117.02bn1.50bn13.68bn1.32k8.741.2010.780.1169250.44250.4419,539.551,826.782.6616.204.3288,854,800.003.402.7112.139.7811.5811.061.280.91740.9764152.760.162732.162.330.5165-7.896.06-6.4211.84
Techno Medica Co Ltd10.28bn1.35bn15.45bn225.009.720.882521.191.50181.53181.531,319.311,998.920.55772.552.65--7.316.688.787.8050.1048.8613.1112.313.85----39.339.781.9617.154.190.71687.67
Japan Medical Dynamic Marketing, INC.23.18bn1.27bn16.87bn488.0013.190.65765.810.727648.3048.30880.53968.740.76090.68154.15--4.296.514.927.5363.6966.975.638.882.11--0.055218.268.786.74-10.68-8.52-2.959.24
HOSHI IRYO-SANKI CO., LTD14.78bn1.39bn17.37bn470.0011.360.92737.511.18447.23447.234,742.975,478.130.667434.485.35--6.375.668.077.1948.7849.049.558.652.86--0.045815.747.256.4211.159.87-13.238.45
Daiken Medical Co Ltd9.75bn988.60m17.48bn188.0015.952.2514.531.7934.4134.41339.39244.440.88563.914.03--8.987.4412.9110.8440.8441.7410.149.281.58752.550.23171.356.713.0138.843.03-4.010.9806
Seed Co Ltd32.40bn1.96bn17.71bn974.007.601.023.690.546576.9476.941,276.55573.500.72332.657.48--4.381.997.533.5143.7842.316.062.740.8037--0.578139.565.891.90721.4415.3020.424.56
Medius Holdings Co Ltd250.78bn847.94m18.60bn2.29k21.810.93647.160.074238.5138.5111,407.31897.032.2717.994.25109,607,600.000.76731.643.176.0212.0511.490.33810.58370.899338.740.565731.155.497.29-19.8015.0942.529.46
Data as of May 21 2024. Currency figures normalised to Techno Medica Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.32%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Mar 2024416.21k4.75%
Nomura Asset Management Co., Ltd.as of 30 Apr 2024150.10k1.71%
Fidelity Investments Canada ULCas of 29 Feb 202490.00k1.03%
Nikko Asset Management Co., Ltd.as of 10 May 202472.70k0.83%
Daiwa Asset Management Co. Ltd.as of 29 Mar 202468.60k0.78%
Dimensional Fund Advisors LPas of 30 Apr 202433.60k0.38%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202430.30k0.35%
VARECS Partners Ltd.as of 15 Dec 202327.40k0.31%
Dimensional Fund Advisors Ltd.as of 29 Feb 20247.81k0.09%
BlackRock Japan Co. Ltd.as of 09 May 20247.50k0.09%
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.